Eloxx Pharmaceuticals, Inc.
ELOX · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $3,943 | $49,674 | $159,497 | $279,764 |
| - Cash | $19,207 | $42,268 | $24,668 | $22,493 |
| + Debt | $13,384 | $13,457 | $12,037 | $15,762 |
| Enterprise Value | -$1,880 | $20,863 | $146,866 | $273,033 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$31,746 | -$64,508 | -$32,597 | -$48,699 |
| % Margin | – | – | – | – |
| Net Income | -$36,065 | -$66,727 | -$34,577 | -$50,874 |
| % Margin | – | – | – | – |
| EPS Diluted | -16.65 | -38.15 | -34.47 | -53.46 |
| % Growth | 56.4% | -10.7% | 35.5% | – |
| Operating Cash Flow | -$31,845 | -$35,001 | -$28,166 | -$39,391 |
| Capital Expenditures | -$66 | -$89 | $0 | -$40 |
| Free Cash Flow | -$31,911 | -$35,090 | -$28,166 | -$39,431 |